CING Stock Discussion

Cingulate Inc. Description

Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Products Neuroscience Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology